Skip to main content

Research Repository

Advanced Search

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

Walker, Alex J.; Baldwin, David R.; Card, Timothy R.; Powell, Helen A.; Hubbard, Richard B.; Grainge, Matthew J.

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data Thumbnail


Authors

Alex J. Walker

David R. Baldwin

Dr TIM CARD tim.card@nottingham.ac.uk
Clinical Associate Professor

Helen A. Powell

RICHARD HUBBARD richard.hubbard@nottingham.ac.uk
Blf/Gsk Professor of Epidemiological Resp Research



Abstract

Background: Venous thromboembolism is a potentially preventable cause of death in people with lung cancer. Identification of those most at risk and high risk periods may provide the opportunity for better targeted intervention.

Methods: We conducted a cohort study using the Clinical Practice Research Datalink linked to Hospital Episode Statistics and Cancer Registry data. Our cohort comprised 10,598 people with lung cancer diagnosed between 1997 and 2006 with follow-up continuing to the end of 2010. Cox regression analysis was performed to determine which demographic, tumour and treatment-related factors (time-varying effects of chemotherapy and surgery) independently affected VTE risk. We also determined the effect of a VTE diagnosis on the survival of people with lung cancer.

Results: People with lung cancer had an overall VTE incidence of 39.2 per 1000 person years (95% confidence Interval (CI), 35.4-43.5), though rates varied depending on the patient group and treatment course. Independent factors associated with increased VTE risk were: metastatic disease (hazard ratio (HR)=1.9, CI 1.2, 3.0 vs. local disease); adenocarcinoma sub-type (HR =2.0, CI 1.5, 2.7, vs. squamous cell; chemotherapy administration, (HR=2.1, CI 1.4, 3.0 vs. outside chemotherapy courses); and diagnosis via emergency hospital admission (HR=1.7, CI 1.2-2.3 vs. other routes to diagnosis). Patients with VTE had an approximately 50% higher risk of mortality than those without VTE.

Conclusions: People with lung cancer have especially high risk of VTE if they have advanced disease, adenocarcinoma, or are undergoing chemotherapy. Presence of VTE is an independent risk factor for death.

Citation

Walker, A. J., Baldwin, D. R., Card, T. R., Powell, H. A., Hubbard, R. B., & Grainge, M. J. (in press). Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. British Journal of Cancer, 115(1), https://doi.org/10.1038/bjc.2016.143

Journal Article Type Article
Acceptance Date Apr 26, 2016
Online Publication Date Jun 2, 2016
Deposit Date Jun 29, 2016
Publicly Available Date Jun 29, 2016
Journal British Journal of Cancer
Print ISSN 0007-0920
Electronic ISSN 1532-1827
Publisher Cancer Research UK
Peer Reviewed Peer Reviewed
Volume 115
Issue 1
DOI https://doi.org/10.1038/bjc.2016.143
Keywords venous thromboembolism
lung cancer
pulmonary embolism
deep vein thrombosis
Public URL https://nottingham-repository.worktribe.com/output/796989
Publisher URL http://www.nature.com/bjc/journal/v115/n1/full/bjc2016143a.html

Files





You might also like



Downloadable Citations